Clinical Trial Update: FLX475 in Combination With Ipilimumab in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of FLX475 in combination with ipilimumab in advanced melanoma was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• FLX475 (FLX475)
• ipilimumab (ipilimumab)

Snippet

Sponsor: RAPT Therapeutics, Inc. | Conditions: Advanced Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2023-12-05